Signal
Grail stock craters as key NHS-Galleri cancer blood test trial fails to hit primary endpoint
Evidence first: scan the strongest sources, then decide whether to go deeper.
Published 2026-02-20 12:47 UTCUpdated 2026-02-20 17:28 UTC
redditrss
grail
Source links open
Source links and full evidence are open here. Archive history, compare-over-time, alerts, exports, API, integrations, and workflow are paid.
No card needed for the free brief.
Evidence trail (top sources)
top sources (1 domains)domains are deduped. counts indicate coverage, not truth.1 top source shown
limited source diversity in top sources
Overview
Grail's multi-cancer test fluffs its lines in UK trial Phil.Taylor Fri, 20/02/2026 - 13:10.
Score total
1.46
Momentum 24h
3
Posts
3
Origins
2
Source types
2
Duplicate ratio
0%
All evidence
All evidence
Grail stock craters as key NHS-Galleri cancer blood test trial fails to hit primary endpoint
biotech · fiercebiotech.com · 2026-02-20 17:28 UTC
Grail's multi-cancer test fluffs its lines in UK trial
pharmaphorum · pharmaphorum.com · 2026-02-20 13:10 UTC
Show filters & breakdown
Posts loaded: 0Publishers: 2Origin domains: 2Duplicates: -
Showing 2 / 0
Top publishers (this list)
- biotech (1)
- pharmaphorum (1)
Top origin domains (this list)
- fiercebiotech.com (1)
- pharmaphorum.com (1)